• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

RFK Jr. names eight new ACIP mem­bers, in­clud­ing pop­u­lar vac­cine crit­ic Robert Mal­one

4 weeks ago
Pharma
FDA+

Trump of­fi­cials seek price de­tails and weigh con­sumer sales as they ex­am­ine most fa­vored na­tion plan

5 weeks ago
Pharma

Trump’s HHS urges against re­viv­ing Cham­ber of Com­merce’s IRA law­suit

5 weeks ago
Pharma
Law

Fed­er­al of­fi­cials sched­ule three lis­ten­ing ses­sions this sum­mer to ad­dress drug com­pe­ti­tion

5 weeks ago
Pharma

Ex­clu­sive: Organoid start­up rais­es $21M to test drugs and vac­cines in hu­man lymph nodes-in-a-dish

5 weeks ago
Startups
R&D

House ap­pro­pri­a­tors call for FDA tweaks on ac­cel­er­at­ed ap­provals, biosim­i­lars

5 weeks ago
R&D
FDA+

Nu­va­tion Bio scores first FDA ap­proval for new lung can­cer drug

5 weeks ago
Pharma
FDA+

Watch Post-Hoc Live: What hap­pens when AI thinks in ways we can’t un­der­stand?

5 weeks ago
Editor's note
R&D

Ca­balet­ta Bio shares CAR-T re­sults in three au­toim­mune con­di­tions

5 weeks ago
R&D

Lil­ly pledges more than $650M to mus­cle health biotech; Co­gent gets $50M

5 weeks ago
News Briefing

Vaxart shares surge on norovirus vac­cine da­ta as it seeks fund­ing for new tri­als

5 weeks ago
R&D

Have sky-high sales pro­jec­tions set the obe­si­ty mar­ket up to fail?

5 weeks ago
Pharma
In Focus

Up­dat­ed: No­vo makes an­oth­er car­diometa­bol­ic deal fo­cused on oral med­i­cines

5 weeks ago
Startups
Deals

BMS’ Rayze­Bio inks ra­dio­phar­ma deal in prostate can­cer for $350M up­front

5 weeks ago
Deals
R&D

Base­camp pitch­es a fix for AI bio's 'da­ta wal­l'

5 weeks ago
AI

Gene ther­a­py biotech Splice­Bio gets $135M short­ly af­ter start­ing first clin­i­cal tri­al

5 weeks ago
Financing
Startups

Ver­tex lays off 125 work­ers af­ter type 1 di­a­betes cell ther­a­py failed study in March

5 weeks ago
People
Pharma

Ar­genx says its drug Vyv­gart looks promis­ing in two more au­toim­mune dis­eases

5 weeks ago
R&D
Pharma

FDA’s Makary says he wasn’t part of de­ci­sion to gut ACIP, de­fers pos­si­ble VRB­PAC changes to Prasad

5 weeks ago
R&D
Pharma

FDA places hold on Gilead­'s stud­ies of HIV treat­ment pill com­bo

5 weeks ago
R&D
FDA+

Post-Hoc Live: The fall­out from RFK Jr.’s fir­ing of ACIP, with ex-CDC Di­rec­tor Mandy Co­hen

5 weeks ago
Editor's note

In­smed’s stock ral­lies on PAH da­ta; Uni­cy­cive aims to re­solve CD­MO is­sues

5 weeks ago
News Briefing

Next in line for a dig­i­tal health IPO

5 weeks ago
Health Tech

Ex­clu­sive: Re­boot­ing dead hu­man brains, a biotech start­up seeks to rein­vent ear­ly drug test­ing work

5 weeks ago
R&D
In Focus
First page Previous page 891011121314 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times